Percutaneous transvenous mitral commissurotomy in mitral stenosis and left atrial appendage clot patients in special

Rajib Rajbhandari1, Rabi Malla1, Arun Maskey1

  • 1Shahid Gangalal National Heart Centre, Kathmandu, Nepal.

Indian Heart Journal
|December 10, 2016
PubMed

Insights

Percutaneous transvenous mitral commissurotomy is safe for mitral stenosis patients with left atrial appendage clot in urgent situations. This procedure offers an acceptable solution, improving outcomes without immediate complications.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Mitral stenosis is a condition often treated with percutaneous transvenous mitral commissurotomy (PTMC).
  • Left atrial appendage (LAA) clot is a common complication that prevents patients from undergoing PTMC.
  • Urgent intervention is sometimes necessary for patients with mitral stenosis and LAA clot who cannot receive anticoagulation.

Purpose of the Study:

  • To evaluate the feasibility and safety of PTMC in patients with mitral stenosis and LAA clot requiring urgent intervention.
  • To assess the procedural success and immediate outcomes in this specific patient cohort.

Main Methods:

  • Twenty patients with mitral stenosis (mitral valve area <1.5cm²), significant dyspnea, LAA clot, and urgent intervention needs were selected.
  • The study was conducted between January 2011 and December 2013 at Shahid Gangalal National Heart Centre, Kathmandu.
  • Informed consent and ethical approval were obtained prior to the procedure.

Main Results:

  • PTMC successfully increased the mean mitral valve area from 0.90cm² to 1.5cm² (p=0.02).
  • Mean left atrial pressure decreased from 20mmHg to 10mmHg, with subjective improvement reported in all patients.
  • No mortality, neurological complications, or need for emergency surgery occurred during the hospital stay or one-week follow-up.

Conclusions:

  • PTMC is a safe and feasible procedure for selected mitral stenosis patients with LAA clot in urgent situations.
  • The procedure yields acceptable immediate results when performed by experienced clinicians.
  • This approach provides a viable treatment option for patients who cannot undergo standard anticoagulation therapy.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
404
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.0K
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
374
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
484
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
918
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
337